Part I: Learn from 2025, Transform in 2026.

How 2025’s Health Trends Pulled Us In—and Ultimately Let Us Down

A new year is approaching, which makes this the perfect moment to get a head start. But moving forward requires first looking back. If we don’t understand what shaped our decisions in 2025, we’re likely to carry the same patterns straight into 2026. Because so many resolutions revolve around wellness, this two-part series takes a clear look at the options we actually have. 

There’s an easy way to pursue change — and a hard way — and only one creates results that last. Shortcuts are tempting because they spare us discomfort, and that’s a very human impulse. But they rarely bring us closer to the health we truly want for ourselves.

Three quick-fix trends in particular defined 2025: GLP-1 drugs, the protein-everything boom, and the “wholesome ingredients” revival.

Each holds a partial truth — enough to feel appealing — but each can quietly derail real health if misunderstood. If 2026 is going to be different, we have to learn from 2025.

Before the new year begins, we need to get honest about what truly moves us forward.

I. Outsourcing Your Appetite

GLP-1 medications — Ozempic, Wegovy, Mounjaro — reshaped the health landscape in 2025. Nearly 12% of U.S. adults report having used one [1], and analysts predict GLP-1 households may account for 35% of all food and beverage sales by 2030 [2]. The cultural impact is massive. And the appeal is obvious: effortless appetite suppression, rapid weight loss, fewer cravings. 

But the ease comes with trade-offs. Up to 40% of users experience nausea or vomiting because these treatments activate sickness pathways in the brain, not just hunger pathways [3]. Hundreds have reported acute pancreatitis, and it’s now being investigated [4]. About half say the drugs are difficult to afford [5].

Recent findings also suggest these medications may only temporarily dampen “food noise,” making people think less about food at first, but without changing the body’s built-in hunger controls [6]. Consistent with this, long-term data show that weight often returns once the intervention is discontinued [7].

And that is the central limitation: GLP-1s may shift appetite in the moment, but they do not teach the body — or the person — how to nourish themselves for life. They can interrupt overeating, but they cannot build the habits, skills, and metabolic resilience that sustain long-term health. Without those deeper shifts, the medication creates a pause — not a transformation.

II. From “More” to “Too Much”

Protein dominated the 2025 food landscape. Suddenly everything came in a high-protein version — breads, chips, yogurt, cereal, pasta, cookies, even drinks — reflecting a wave of industry reformulation [8]. And because protein is essential for satiety and metabolic function, the trend felt intuitively healthy. But more protein isn’t always better.

When meals become protein-heavy, they inevitably leave less room for fruits, vegetables, legumes, and whole grains — the foods that supply fiber, antioxidants, and phytonutrients that support long-term well-being. That imbalance is meaningful, because most Americans already struggle to meet even basic produce recommendations, such as five to nine daily servings [9], while routinely consuming more protein than they need [10]. 

And even the satiety benefits people expect from protein have limits: research shows that when habitual protein intake is already high, its ability to promote fullness diminishes [11]. Taken together, these patterns help explain why high animal-protein diets — especially when they displace plant foods — are associated with increased cardiovascular and cancer risk [12].

The protein craze made healthy eating feel simple, but real nutrition is rarely that one-dimensional. Health isn’t built by elevating a single macronutrient — it’s built by giving the whole body what it actually needs.

III. Nostalgia Isn’t Nutrition Advice

Another 2025 trend was the embrace of “ancestral eating” and a romantic return to “real” foods like beef tallow, whole milk, and eggs. These ingredients were framed as simple, pure, and nutritionally superior. Although the idea of “wholesome” felt comforting, comfort and physiology don’t always align.

Beef tallow is often marketed as “natural,” but it’s very high in saturated fat [13], the kind that raises low-density lipoprotein (LDL) cholesterol and increases heart-disease risk [14]. Whole milk, though traditionally valued, is high in saturated fat which—together with its modest cholesterol content—may contribute to elevated cholesterol levels in adults [15]. And eggs, despite their “whole food” image, are rich in dietary cholesterol and have been associated with higher cardiovascular and mortality risk [16].

Meanwhile, many processed plant foods — like tofu, tempeh, and fortified plant milks — consistently support positive health outcomes, underscoring that processing itself does not determine whether a food is healthy [17].

This trend trades evidence for narrative, when what really matters is the nutrient profile, not the story we attach to the food.

IV. Tools, Not Foundations

Each of 2025’s major wellness shifts revealed something real — and each carried a deeper lesson we can’t afford to miss.

GLP-1 drugs showed how difficult weight loss can feel, but also that no medication can replace learning how to eat well for life. They can spark progress, but without nutrition and habit change, the benefits fade.

The protein boom highlighted the importance of nourishment, yet reminded us that leaning too hard on any one nutrient can backfire. Adequate protein matters; excess crowds out the fiber-rich plant foods that protect long-term health.

The return to “wholesome” foods reflected a desire for simplicity, but also how easily appearances can mislead. Not all “wholesome” foods are beneficial, and not all processed foods are harmful — food quality is what matters.

Each trend speaks to a real need, but none is a complete plan. Used as systems, they become detours; used wisely, they offer support. If 2026 is to be a year of real change, we must move beyond the convenient and the familiar, and choose what genuinely sustains us.

V. Where We Go from Here

2025 taught us something vital: easy doesn’t heal. Easy delays. Easy distracts. The harder path — nourishment, consistency, movement, rest, and genuine self-care — is the one that creates lasting change.

And that is where Part II begins.

For 2026, the shift is sustainable care — a steady pattern of choices that strengthen you over time. Ahead, we’ll explore how to build that kind of foundation into a life that truly supports your health, not just your hopes.

You can read more about this in Part II, here: https://vegancurator.com/blog/what-sustains-you-in-2026

References

[1] RAND Corporation. “Nearly 12 Percent of Americans Have Used GLP-1 Weight-Loss Drugs; Medications Are Most Used by Women Aged 50 to 64.” August 6, 2025. https://www.rand.org/news/press/2025/08/nearly-12-percent-of-americans-have-used-glp-1-weight.html.

[2] Zimmerman, Sarah. “GLP-1 Users to Make Up 35% of Food and Beverage Sales by 2030: Report.” Food Dive, November 25, 2025. https://www.fooddive.com/news/glp1s-weight-loss-food-beverage-sales-2030/806415/.

[3] “How to Keep Ozempic/Wegovy Weight Loss Without the Nausea.” ScienceDaily, November 18, 2025. https://www.sciencedaily.com/releases/2025/11/251118220041.htm.

[4] Bawden, Anna. “Hundreds of Weight-Loss and Diabetes Jab Users Report Pancreas Problems.” The Guardian, June 25, 2025. https://www.theguardian.com/society/2025/jun/26/weight-loss-diabetes-jab-users-report-pancreas-problems.

[5] KFF. “Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford.” November 14, 2025. https://www.kff.org/public-opinion/poll-1-in-8-adults-say-they-are-currently-taking-a-glp-1-drug-for-weight-loss-diabetes-or-another-condition-even-as-half-say-the-drugs-are-difficult-to-afford/.

[6] Penn Medicine. “GLP-1 Drugs May Only Temporarily Quiet ‘Food Noise,’ Study Finds.” November 26, 2024. https://www.pennmedicine.org/news/tirzepatide-may-only-temporarily-quiet-food-noise.

[7] Choi, W., Y. H. Nho, L. Qiu, et al. “Brain Activity Associated with Breakthrough Food Preoccupation in an Individual on Tirzepatide.” Nature Medicine (2025). https://doi.org/10.1038/s41591-025-04035-5. https://www.nature.com/articles/s41591-025-04035-5.

[8] Wilding, J. P. H., R. L. Batterham, M. Davies, L. F. Van Gaal, K. Kandler, K. Konakli, I. Lingvay, B. M. McGowan, T. K. Oral, J. Rosenstock, T. A. Wadden, S. Wharton, K. Yokote, and R. F. Kushner; STEP 1 Study Group. “Weight Regain and Cardiometabolic Effects After Withdrawal of Semaglutide: The STEP 1 Trial Extension.” Diabetes, Obesity and Metabolism 24, no. 8 (2022): 1553–64. https://pubmed.ncbi.nlm.nih.gov/35441470/.

[9] Grand View Research. “Protein-fortified Food Products Market Size, Share & Trends Analysis Report, 2024–2030.” 2024. https://www.grandviewresearch.com/industry-analysis/protein-fortified-food-products-market-report.

[10] Moore, L. V., and F. E. Thompson. “Adults Meeting Fruit and Vegetable Intake Recommendations — United States, 2013.” Morbidity and Mortality Weekly Report 64, no. 26 (2015): 709–13. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6426a1.htm.

[11] Long, S. J., A. R. Jeffcoat, and D. J. Millward. “Effect of Habitual Dietary-Protein Intake on Appetite and Satiety.” Appetite 35, no. 1 (2000): 79–88. https://pubmed.ncbi.nlm.nih.gov/10896764/.

[12] Song, M., T. T. Fung, F. B. Hu, et al. “Association of Animal and Plant Protein Intake With All-Cause and Cause-Specific Mortality.” JAMA Internal Medicine 176, no. 10 (2016): 1453–63. https://doi.org/10.1001/jamainternmed.2016.4182. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2540540.

[13] Cleveland Clinic. “Beef Tallow for Cooking: Is It Healthy?” Health Essentials, July 18, 2023. https://health.clevelandclinic.org/beef-tallow-for-cooking.

[14] Harvard T.H. Chan School of Public Health. “Ask the Expert: Healthy Fats.” The Nutrition Source, June 21, 2012. https://nutritionsource.hsph.harvard.edu/2012/06/21/ask-the-expert-healthy-fats/#good-fats.

[15] Arnesen, E. K., J. J. Christensen, I. Laake, M. H. Carlsen, M. B. Veierød, and K. Retterstøl. “Low-Fat and Whole Milk Consumption in Relation to Cardiovascular Disease–Related and All-Cause Mortality: A Prospective Cohort Study in Three Norwegian Counties.” American Journal of Clinical Nutrition 122, no. 4 (2025): 1075–85. https://doi.org/10.1016/j.ajcnut.2025.07.035. https://pubmed.ncbi.nlm.nih.gov/40759395/.

[16] Chen, G. C., L. H. Chen, Y. Mossavar-Rahmani, et al. “Dietary Cholesterol and Egg Intake in Relation to Incident Cardiovascular Disease and All-Cause and Cause-Specific Mortality in Postmenopausal Women.” American Journal of Clinical Nutrition 113, no. 4 (2021): 948–59. https://doi.org/10.1093/ajcn/nqaa353.

[17] Jiménez, Mariana Del Carmen Fernández-Fígares, and Miguel López-Moreno. “Ultra-Processed Plant Foods: Are They Worse than Their Unprocessed Animal-Based Counterparts?” Current Nutrition Reports 14 (2025): 115. https://doi.org/10.1007/s13668-025-00704-6.